1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Code

Showing 1,267 results.

$Thumbnail for Efficacy and Differentiation Syndrome With Menin Inhibitors in Relapsed/Refractory KMT2A-Rearranged or NPM1-Mutated Acute Leukemia: An Exploratory Proportional Meta-Analysis$

AML - 848

Efficacy and Differentiation Syndrome With Menin Inhibitors in Relapsed/Refractory KMT2A-Rearranged or NPM1-Mutated Acute Leukemia: An Exploratory Proportional Meta-Analysis

Farzeen Fatma Syed

Poster Presenter: Farzeen Fatma Syed

Thumbnail for Prevalence of Standard Modifiable Risk Factors and Associated Cardiovascular Events Among Patients Hospitalized With Acute Myeloid Leukemia: A Nationwide Inpatient Analysis (2016-2022)

AML - 849

Prevalence of Standard Modifiable Risk Factors and Associated Cardiovascular Events Among Patients Hospitalized With Acute Myeloid Leukemia: A Nationwide Inpatient Analysis (2016-2022)

Aishwarya Ramesh

Poster Presenter: Aishwarya Ramesh

SOHO 2026 Annual Meeting

Posters by Code

Efficacy and Differentiation Syndrome With Menin Inhibitors in Relapsed/Refractory KMT2A-Rearranged or NPM1-Mutated Acute Leukemia: An Exploratory Proportional Meta-Analysis

Prevalence of Standard Modifiable Risk Factors and Associated Cardiovascular Events Among Patients Hospitalized With Acute Myeloid Leukemia: A Nationwide Inpatient Analysis (2016-2022)

Clinical and Molecular Features of Adult-Onset KRAS-Mutant Leukoproliferative Disorder With Monocytosis

FIRST-LINE TREATMENT OUTCOMES IN TP53-MUTATED ACUTE MYELOID LEUKEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS

GLP-1 Receptor Agonists and SGLT2 Inhibitors in Multiple Myeloma and Plasma Cell Disorders: Protective, Harmful, or Both? A Scoping Review

Vispa-cel, an Allogeneic Anti-CD19 CAR-T Cell Therapy with a PD-1 Knockout, in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER Phase 1 Clinical Trial)

Racial and Ethnic Disparities in Acute Myeloid Leukemia Transformation After Myelodysplastic Syndrome: A Population-Based Analysis of Incidence and Latency

Efficacy of Midostaurin Therapy and Allogeneic Bone Marrow Transplantation in Patients With Advanced Systemic Mastocytosis

IVIG Replacement Therapy and Clinical Outcomes in Adults With Hematologic Malignancies and Secondary Hypogammaglobulinemia: A Propensity Score-Matched Analysis